---
$id: https://graph.org.ai/products/commodity/51283947
$type: Product
source: UNSPSC
code: "51283947"
title: "Sulfadiazine sodium"
class: "51283900"
classTitle: "Sulfonamide antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sulfadiazine sodium

**UNSPSC Code**: 51283947
**Class**: [Sulfonamide antibacterials](Sulfonamide antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a sulfonamide anti-infective agent with the molecular formula C10H9N4O2S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 84CS1P306F, chemically known as trisulfapyrimidine, oral suspension but more generally known as sulfadiazine sodium, which bears US NIH Compound Identifier 5215. European Medicines Agency schedules Sulfadiazine sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10696MIG. The term SULFADIAZINE SODIUM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). Most nations, for tariff and trade purposes, schedule sulfadiazine sodium under HS 29350090 and SITC 51580. As of Q4 2014, SULFADIAZINE SODIUM remains US FDA's Preferred Term for this commodity. Sulfadiazine sodium bears US NLM identifiers UMLS ID C0723509 and NCI Concept Code C66566. SMILES: C1CNC(NC1)[N-]S(=O)(=O)C2CCC(CC2)N.[NA+].

